360 NEWS360 NEWS

Healthcare · National

Experimental GLP-1 drug demonstrates pain relief in people with osteoarthritis during trials

A pooled analysis of the studies found that about two-thirds of participants receiving the drug retatrutide experienced at least a 50% reduction in knee pain, compared with 38% of those receiving a placebo

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on “Experimental GLP-1 drug demonstrates pain relief in people with osteoarthritis during trials”?

This is self-selected reader participation, not representative scientific polling.